Just to recap for those who can't listen at work:
1250 plus patients enrolled, study is complete and results are being analyzed now
Mid to late July the results are expected
Submission to FDA de novo class 2 in August
FDA clearance expected before end of calendar year
This part is interesting:
Pricing model is to charge every time the test is used in consultation, they are looking at around 5 to 10 USD each test. They expect at least "in the 10's of millions" of tests to take place in the states alone.
- Forums
- ASX - By Stock
- Game On
Just to recap for those who can't listen at work: 1250 plus...
-
- There are more pages in this discussion • 307 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)